Literature DB >> 20385529

Ophthalmological findings in children and young adults with genetically verified mitochondrial disease.

M A Grönlund1, A K Seyedi Honarvar, S Andersson, A R Moslemi, A Oldfors, E Holme, M Tulinius, N Darin.   

Abstract

AIM: To describe ophthalmological phenotypes in patients with mitochondrial disease and known genotypes.
METHODS: A retrospective study was performed on 59 patients (29 male, 30 female) with a mean age of 11.8 years who had mitochondrial disease with known DNA mutations. Fifty-seven of the 59 subjects underwent a detailed ophthalmological examination including visual acuity (VA), eye motility, refraction, slit-lamp examination, ophthalmoscopy and, in almost one-half of the cases, a full-field electroretinogram (ERG).
RESULTS: Forty-six (81%) of the patients had one or more ophthalmological findings such as ptosis (n = 16), reduced eye motility (n = 22) including severe external ophthalmoplegia (n = 9), strabismus (n = 4), nystagmus (n = 9), low VA (n = 21), refractive errors (n = 26), photophobia (n = 4), and partial or total optic atrophy (n = 25). Pigmentation in the macula and/or periphery was noted in 16 patients. In 10/27 investigated individuals with full field ERG, retinal dystrophy was recorded in six different genotypes representing Kearns-Sayre syndrome (n = 5), Leigh syndrome (n = 1), Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) (n = 1), Myoclonus epilepsy with red ragged fibres (MERRF) (n = 1), Leber hereditary optic neuropathy (n = 1) and mitochondrial myopathy (n = 1).
CONCLUSION: The results show that a majority of patients with mitochondrial disorders have ophthalmological abnormalities. We recommend that an ophthalmological examination, including ERG, be performed on all children and adolescents who are suspected of having a mitochondrial disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20385529     DOI: 10.1136/bjo.2008.154187

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  18 in total

1.  Diagnosis of mitochondrial disorders applying massive pyrosequencing.

Authors:  Marcelo Andrés Kauffman; Dolores Gonzlez-Morón; Damián Consalvo; Gastón Westergaard; Martín Vazquez; Estefanía Mancini; Ana Lía Taratuto; Raúl Rey; Silvia Kochen
Journal:  Mol Biol Rep       Date:  2012-06       Impact factor: 2.316

Review 2.  Mitochondrial genetic diseases.

Authors:  Marni J Falk; Neal Sondheimer
Journal:  Curr Opin Pediatr       Date:  2010-12       Impact factor: 2.856

Review 3.  Mitochondrial disorders and the eye.

Authors:  Samantha A Schrier; Marni J Falk
Journal:  Curr Opin Ophthalmol       Date:  2011-09       Impact factor: 3.761

4.  Pearls & oy-sters: maternally inherited diabetes and deafness presenting with ptosis and macular pattern dystrophy.

Authors:  Olufunmilola Ogun; Claire Sheldon; Jason J S Barton
Journal:  Neurology       Date:  2012-08-07       Impact factor: 9.910

5.  Visual pathways evaluation in Kearns Sayre syndrome: a diffusion tensor imaging study.

Authors:  Maria Camilla Rossi-Espagnet; Martina Lucignani; Luca Pasquini; Antonio Napolitano; Stefano Pro; Andrea Romano; Daria Diodato; Diego Martinelli; Daniela Longo
Journal:  Neuroradiology       Date:  2019-11-04       Impact factor: 2.804

Review 6.  Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.

Authors:  Patrick Yu-Wai-Man; Philip G Griffiths; Patrick F Chinnery
Journal:  Prog Retin Eye Res       Date:  2010-11-26       Impact factor: 21.198

7.  Photoreceptors in a mouse model of Leigh syndrome are capable of normal light-evoked signaling.

Authors:  Sidney M Gospe; Amanda M Travis; Alexander V Kolesnikov; Mikael Klingeborn; Luyu Wang; Vladimir J Kefalov; Vadim Y Arshavsky
Journal:  J Biol Chem       Date:  2019-06-27       Impact factor: 5.157

Review 8.  Mitochondrial disease in childhood: nuclear encoded.

Authors:  Amy C Goldstein; Poonam Bhatia; Jodie M Vento
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

9.  Ophthalmic Manifestations and Long-Term Visual Outcomes in Patients with Cobalamin C Deficiency.

Authors:  Brian P Brooks; Amy H Thompson; Jennifer L Sloan; Irini Manoli; Nuria Carrillo-Carrasco; Wadih M Zein; Charles P Venditti
Journal:  Ophthalmology       Date:  2016-01-26       Impact factor: 12.079

10.  Mitochondrial Disease: Advances in clinical diagnosis, management, therapeutic development, and preventative strategies.

Authors:  Colleen C Muraresku; Elizabeth M McCormick; Marni J Falk
Journal:  Curr Genet Med Rep       Date:  2018-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.